SEC 13F Intelligence

Harvey Investment Co LLC / ABT

Harvey Investment Co LLC’s Abbott Laboratories Position

Does Harvey Investment Co LLC own Abbott Laboratories (ABT)? Yes — 250.8K shares worth $26M (+2.83% of its 13F portfolio) as of Q1 2026, up from 241.8K shares the prior filed quarter.

Position Value
$26M
Q1 2026
Shares
250.8K
% of Portfolio
+2.83%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $18MQ4 ’18Q1 ’19: $20MQ2 ’19: $21MQ3 ’19: $20MQ4 ’19: $21MQ4 ’19Q1 ’20: $19MQ2 ’20: $21MQ3 ’20: $25MQ4 ’20: $25MQ4 ’20Q1 ’21: $27MQ2 ’21: $26MQ3 ’21: $27MQ4 ’21: $32MQ4 ’21Q1 ’22: $27MQ2 ’22: $24MQ3 ’22: $22MQ4 ’22: $24MQ4 ’22Q1 ’23: $23MQ2 ’23: $25MQ3 ’23: $22MQ4 ’23: $26MQ4 ’23Q1 ’24: $26MQ2 ’24: $24MQ3 ’24: $28MQ4 ’24: $28MQ4 ’24Q1 ’25: $32MQ2 ’25: $33MQ3 ’25: $33MQ4 ’25: $30MQ4 ’25Q1 ’26: $26Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026250.8K$26M+2.83%
Q4 2025241.8K$30M+3.23%
Q3 2025243.5K$33M+3.48%
Q2 2025243.5K$33M+3.64%
Q1 2025243.5K$32M+3.59%
Q4 2024243.5K$28M+3.18%
Q3 2024243.6K$28M+3.14%
Q2 2024231.6K$24M+2.88%
Q1 2024229.6K$26M+2.94%
Q4 2023232.6K$26M+3.10%
Q3 2023230.2K$22M+2.92%
Q2 2023231.2K$25M+3.30%
Q1 2023231.4K$23M+2.91%
Q4 2022223.1K$24M+3.16%
Q3 2022224.3K$22M+3.15%
Q2 2022224.4K$24M+3.43%
Q1 2022224.9K$27M+3.26%
Q4 2021225.3K$32M+3.67%
Q3 2021227.1K$27M+3.49%
Q2 2021227.4K$26M+3.48%
Q1 2021226.0K$27M+3.86%
Q4 2020231.6K$25M+3.57%
Q3 2020232.4K$25M+3.95%
Q2 2020232.3K$21M+3.60%
Q1 2020238.1K$19M+3.68%
Q4 2019242.8K$21M+3.25%
Q3 2019243.4K$20M+3.37%
Q2 2019244.0K$21M+3.46%
Q1 2019244.2K$20M+3.35%
Q4 2018250.6K$18M+3.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harvey Investment Co LLC’s full portfolio or all institutional holders of ABT.